These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 1278018

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [A successfully treated case of spironolactone-induced hyperkalemic quadriplegia].
    Radó J, Csabuda M.
    Orv Hetil; 1985 Aug 11; 126(32):1967-70, 1973-4. PubMed ID: 2993981
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of hyperkalemia with polystyrene-sulfonate ion exchange resins].
    Svejda J.
    Vnitr Lek; 1969 Aug 11; 15(8):804-6. PubMed ID: 5810002
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of hyperkalemia associated with renal insufficiency--clinical effects and side reactions of positive-ion-exchange resins, sodium polystyrene sulfonate (Kayexalate)].
    Takasu T.
    Nihon Rinsho; 1970 Jul 11; 28(7):1941-6. PubMed ID: 5466528
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Resin treatment of hyperkalemia. II. Clinical experience with a cation exchange resin (calcium cycle).
    Frohnert PP, Johnson WJ, Mueller GJ, Tauxe WN, McCall JT.
    J Lab Clin Med; 1968 May 11; 71(5):840-6. PubMed ID: 5647685
    [No Abstract] [Full Text] [Related]

  • 11. [Urea and spironolactone therapy].
    Schwarzbach W, Bunzl W.
    Munch Med Wochenschr; 1973 Jan 19; 115(3):76-80. PubMed ID: 4739290
    [No Abstract] [Full Text] [Related]

  • 12. [Late drug-induced hyperkalemia in a patient with congestive heart failure].
    Konopa J, Bułło B, Rutkowski B.
    Przegl Lek; 2005 Jan 19; 62(7):732-3. PubMed ID: 16463712
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of hyperkalemia in renal insufficiency with cation exchange resin. Experience with use of sodium polystyrene sulfonate].
    Osawa A, Okoshi M, Higuchi J, Yamayoshi W.
    Hinyokika Kiyo; 1969 Sep 19; 15(9):645-51. PubMed ID: 5388724
    [No Abstract] [Full Text] [Related]

  • 14. [Let's read the domestic literature. ACE-inhibitors and spironolactone-induced hyperkalemia].
    Radó J.
    Orv Hetil; 2002 Aug 04; 143(31):1868; author reply 1868. PubMed ID: 12187583
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors predicting hyperkalemia in patients with cirrhosis receiving spironolactone.
    Abbas Z, Mumtaz K, Salam A, Jafri W.
    J Coll Physicians Surg Pak; 2003 Jul 04; 13(7):382-4. PubMed ID: 12887837
    [Abstract] [Full Text] [Related]

  • 18. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP, Aaronson KD, Koelling TM.
    Am Heart J; 2004 Dec 04; 148(6):971-8. PubMed ID: 15632880
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases].
    Svensson M, Gustafsson F, Galatius S, Hildebrandt PR, Atar D.
    Ugeskr Laeger; 2004 Sep 06; 166(37):3201-3. PubMed ID: 15384373
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.